Primary pulmonary hypertension and Costochondritis


Costochondritis is found among people with Primary pulmonary hypertension, especially for people who are female, 40-49 old.

The study analyzes which people have Costochondritis with Primary pulmonary hypertension. It is created by eHealthMe based on reports of 35 people who have Primary pulmonary hypertension from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Sep, 26, 2022

35 people who have Primary Pulmonary Hypertension and Costochondritis are studied.

What is Primary pulmonary hypertension?

Primary pulmonary hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart) is found to be associated with 1,216 drugs and 753 conditions by eHealthMe.

What is Costochondritis?

Costochondritis (chest wall pain) is found to be associated with 1,000 drugs and 550 conditions by eHealthMe.

Number of Costochondritis in Primary pulmonary hypertension reports submitted per year:

Would you have Costochondritis when you have Primary pulmonary hypertension?

Gender of people who have Primary Pulmonary Hypertension and experienced Costochondritis *:

  • female: 96.67 %
  • male: 3.33 %

Age of people who have Primary Pulmonary Hypertension and experienced Costochondritis *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 3.5700000000000003 %
  • 20-29: 3.5700000000000003 %
  • 30-39: 0.0 %
  • 40-49: 46.43 %
  • 50-59: 25.0 %
  • 60+: 21.43 %

Common co-existing conditions for these people *:

  1. Lung Disorder (lung disease): 1 person, 2.86%
  2. Connective Tissue Disorder (any disease that has the connective tissues of the body): 1 person, 2.86%

Common drugs taken by these people *:

  1. Opsumit: 18 people, 51.43%
  2. Lasix: 11 people, 31.43%
  3. Revatio: 11 people, 31.43%
  4. Adcirca: 10 people, 28.57%
  5. Tracleer: 7 people, 20.00%
  6. Torsemide: 6 people, 17.14%
  7. Albuterol: 6 people, 17.14%
  8. Potassium: 6 people, 17.14%
  9. Betapace: 5 people, 14.29%
  10. Chlor-Trimeton: 5 people, 14.29%

Common symptoms for these people *:

  1. Chest Pain: 29 people, 82.86%
  2. Breathing Difficulty: 21 people, 60.00%
  3. Joint Pain: 12 people, 34.29%
  4. Dizziness: 12 people, 34.29%
  5. Fall: 11 people, 31.43%
  6. Fatigue (feeling of tiredness): 10 people, 28.57%
  7. Sinusitis (inflammation of sinus): 9 people, 25.71%
  8. Dyspnea Exertional: 9 people, 25.71%
  9. Hypoaesthesia (reduced sense of touch or sensation): 7 people, 20.00%
  10. Diarrhea: 7 people, 20.00%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Costochondritis?

Check whether Costochondritis is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

Treatments, associated drugs and conditions:

COVID vaccines that are related to Costochondritis:

Common drugs associated with Costochondritis:

All the drugs that are associated with Costochondritis:

Common conditions associated with Costochondritis:

All the conditions that are associated with Costochondritis:

How the study uses the data?

The study is based on Costochondritis and Primary pulmonary hypertension, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).


WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: